alPHa (JnJ) 17+
Janssen EMEA
-
- Gratis
iPad-Screenshots
Beschreibung
The Alpha Application (the “App”) has been developed and funded by Actelion Pharmaceuticals Ltd (“Actelion”) with the sole purpose of serving as an educational tool on Pulmonary Arterial Hypertension for health care professionals. If you are not a health care professional, you must not use the App. By installing and starting the App, you confirm that you are a health care professional.
The App serves as an instrument complementing, not replacing, other educational means. The intent of the App is not to provide any specific treatment recommendation. Although the App has been diligently designed, it may not be error free. Although we do make reasonable endeavours to ensure that the information provided is both timely and accurate, the information provided via this App is: (i) of a general educational nature only and is not intended to address the specific circumstances of any particular individual; (ii) not necessarily comprehensive, accurate, complete or up to date;
All patients appearing in the App as patient cases, are based on real clinical experience but the details have been modified for training purpose.
Neuheiten
Version 1.1
Minor security updates
App-Datenschutz
Der Entwickler, Janssen EMEA, hat darauf hingewiesen, dass die Datenschutzrichtlinien der App den unten stehenden Umgang mit Daten einschließen können. Weitere Informationen findest du in den Datenschutzrichtlinien des Entwicklers.
Keine Daten erfasst
Der Entwickler erfasst keine Daten von dieser App.
Die Datenschutzpraktiken können zum Beispiel je nach den von dir verwendeten Funktionen oder deinem Alter variieren. Weitere Infos
Informationen
- Anbieter
- Janssen Pharmaceutica N.V.
- Größe
- 105,5 MB
- Kategorie
- Medizin
- Kompatibilität
-
- iPad
- Erfordert iPadOS 11.0 oder neuer.
- Apple Vision
- Erfordert visionOS 1.0 oder neuer.
- Sprachen
-
Englisch
- Alter
- 17+ Häufig/stark ausgeprägt: medizinische/Behandlungs-Informationen
- Copyright
- © alPHa (JnJ)
- Preis
- Gratis